Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 125 articles:
HTML format
Text format



Single Articles


    February 2018
  1. SHENG C, Qiu J, He Z, Wang H, et al
    Suppression of Kpnbeta1 expression inhibits human breast cancer cell proliferation by abrogating nuclear transport of Her2.
    Oncol Rep. 2018;39:554-564.
    PubMed     Text format     Abstract available


    January 2018
  2. YIN G, Zeng B, Peng Z, Liu Y, et al
    Synthesis and application of 131I-fulvestrant as a targeted radiation drug for endocrine therapy in human breast cancer.
    Oncol Rep. 2018 Jan 11. doi: 10.3892/or.2018.6212.
    PubMed     Text format     Abstract available


  3. WANG YW, Zhang W, Ma R
    Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
    Oncol Rep. 2018 Jan 10. doi: 10.3892/or.2018.6205.
    PubMed     Text format     Abstract available


  4. ZHAO M, Wang Y, Du C, Liu Y, et al
    Aspirin and metformin exhibit antitumor activity in murine breast cancer.
    Oncol Rep. 2018 Jan 4. doi: 10.3892/or.2018.6190.
    PubMed     Text format     Abstract available


  5. KASORN A, Loison F, Kangsamaksin T, Jongrungruangchok S, et al
    Terrein inhibits migration of human breast cancer cells via inhibition of the Rho and Rac signaling pathways.
    Oncol Rep. 2018 Jan 4. doi: 10.3892/or.2018.6189.
    PubMed     Text format     Abstract available


    December 2017
  6. WANG Y, Li L, Wang H, Li J, et al
    Silencing TGIF suppresses migration, invasion and metastasis of MDAMB231 human breast cancer cells.
    Oncol Rep. 2017 Dec 4. doi: 10.3892/or.2017.6133.
    PubMed     Text format     Abstract available


    November 2017
  7. LIN SC, Chu PY, Liao WT, Wu MY, et al
    Glycyrrhizic acid induces human MDA-MB-231 breast cancer cell death and autophagy via the ROS-mitochondrial pathway.
    Oncol Rep. 2017 Nov 29. doi: 10.3892/or.2017.6123.
    PubMed     Text format     Abstract available


  8. ANDROUTSOPOULOS VP, Spandidos DA
    Anticancer pyridines induce G2/M arrest and apoptosis via p53 and JNK upregulation in liver and breast cancer cells.
    Oncol Rep. 2017 Nov 28. doi: 10.3892/or.2017.6116.
    PubMed     Text format     Abstract available


  9. SUI Y, Zhang X, Yang H, Wei W, et al
    MicroRNA-133a acts as a tumour suppressor in breast cancer through targeting LASP1.
    Oncol Rep. 2017 Nov 27. doi: 10.3892/or.2017.6114.
    PubMed     Text format     Abstract available


  10. QIU N, He Y, Zhang S, Hu X, et al
    Cullin 7 is a predictor of poor prognosis in breast cancer patients and is involved in the proliferation and invasion of breast cancer cells by regulating the cell cycle and microtubule stability.
    Oncol Rep. 2017 Nov 21. doi: 10.3892/or.2017.6106.
    PubMed     Text format     Abstract available


  11. AOTO K, Mimura K, Okayama H, Saito M, et al
    Immunogenic tumor cell death induced by chemotherapy in patients with breast cancer and esophageal squamous cell carcinoma.
    Oncol Rep. 2017 Nov 14. doi: 10.3892/or.2017.6097.
    PubMed     Text format     Abstract available


  12. ZHANG W, Pan Y, Gou P, Zhou C, et al
    Effect of xanthohumol on Th1/Th2 balance in a breast cancer mouse model.
    Oncol Rep. 2017 Nov 13. doi: 10.3892/or.2017.6094.
    PubMed     Text format     Abstract available


  13. QIU Y, Liu Y, Li WH, Zhang HQ, et al
    P2Y2 receptor promotes the migration and invasion of breast cancer cells via EMT-related genes Snail and E-cadherin.
    Oncol Rep. 2017 Nov 7. doi: 10.3892/or.2017.6081.
    PubMed     Text format     Abstract available


  14. GONZALEZ-GONZALEZ A, Gonzalez A, Alonso-Gonzalez C, Menendez-Menendez J, et al
    Complementary actions of melatonin on angiogenic factors, the angiopoietin/Tie2 axis and VEGF, in cocultures of human endothelial and breast cancer cells.
    Oncol Rep. 2017 Nov 2. doi: 10.3892/or.2017.6070.
    PubMed     Text format     Abstract available


  15. REN P, Ren X, Cheng L, Xu L, et al
    Frankincense, pine needle and geranium essential oils suppress tumor progression through the regulation of the AMPK/mTOR pathway in breast cancer.
    Oncol Rep. 2017 Nov 1. doi: 10.3892/or.2017.6067.
    PubMed     Text format     Abstract available


    October 2017
  16. JIANG Y, Ji F, Liu Y, He M, et al
    Cisplatin-induced autophagy protects breast cancer cells from apoptosis by regulating yes-associated protein.
    Oncol Rep. 2017 Oct 16. doi: 10.3892/or.2017.6035.
    PubMed     Text format     Abstract available


  17. HOU W, Zhang H, Bai X, Liu X, et al
    Suppressive role of miR-592 in breast cancer by repressing TGF-beta2.
    Oncol Rep. 2017 Oct 12. doi: 10.3892/or.2017.6029.
    PubMed     Text format     Abstract available


  18. HE DX, Wu XL, Lu CX, Gu XT, et al
    Genome-wide analysis of the three-way interplay among gene expression, estrogen receptor expression and chemotherapeutic sensitivity in breast cancer.
    Oncol Rep. 2017 Oct 12. doi: 10.3892/or.2017.6033.
    PubMed     Text format     Abstract available


  19. YANG L, Song Z, Wang X, Yang W, et al
    Huaier extract enhances the treatment efficacy of paclitaxel in breast cancer cells via the NF-kappaB/IkappaBalpha pathway.
    Oncol Rep. 2017 Oct 12. doi: 10.3892/or.2017.6024.
    PubMed     Text format     Abstract available


  20. HAN Y, Zhang L, Wang W, Li J, et al
    Livin promotes the progression and metastasis of breast cancer through the regulation of epithelialmesenchymal transition via the p38/GSK3beta pathway.
    Oncol Rep. 2017 Oct 10. doi: 10.3892/or.2017.6017.
    PubMed     Text format     Abstract available


    September 2017
  21. ZHOU T, Zhang A, Kuang G, Gong X, et al
    Baicalin inhibits the metastasis of highly aggressive breast cancer cells by reversing epithelial-to-mesenchymal transition by targeting beta-catenin signaling.
    Oncol Rep. 2017 Sep 28. doi: 10.3892/or.2017.6011.
    PubMed     Text format     Abstract available


  22. ONO H, Iizumi Y, Goi W, Sowa Y, et al
    Ribosomal protein S3 regulates XIAP expression independently of the NF-kappaB pathway in breast cancer cells.
    Oncol Rep. 2017 Sep 27. doi: 10.3892/or.2017.6008.
    PubMed     Text format     Abstract available


  23. AN J, Wang L, Zhao Y, Hao Q, et al
    Effects of FSTL1 on cell proliferation in breast cancer cell line MDAMB231 and its brain metastatic variant MDAMB231BR.
    Oncol Rep. 2017 Sep 26. doi: 10.3892/or.2017.6004.
    PubMed     Text format     Abstract available


  24. ZHANG Y, Wang DL, Yan HY, Liao JY, et al
    Genome-wide study of ER-regulated lncRNAs shows AP000439.3 may function as a key regulator of cell cycle in breast cancer.
    Oncol Rep. 2017 Sep 20. doi: 10.3892/or.2017.5975.
    PubMed     Text format     Abstract available


  25. TANG CP, Zhou HJ, Qin J, Luo Y, et al
    MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer.
    Oncol Rep. 2017 Sep 19. doi: 10.3892/or.2017.5968.
    PubMed     Text format     Abstract available


  26. ZHAO Y, Ge CC, Wang J, Wu XX, et al
    MEK inhibitor, PD98059, promotes breast cancer cell migration by inducing beta-catenin nuclear accumulation.
    Oncol Rep. 2017 Sep 13. doi: 10.3892/or.2017.5955.
    PubMed     Text format     Abstract available


    August 2017
  27. OH YJ, Seo YH
    A novel chalcone-based molecule, BDP inhibits MDAMB231 triple-negative breast cancer cell growth by suppressing Hsp90 function.
    Oncol Rep. 2017 Aug 25. doi: 10.3892/or.2017.5925.
    PubMed     Text format     Abstract available


  28. GUO J, Gong G, Zhang B
    Screening and identification of potential biomarkers in triple-negative breast cancer by integrated analysis.
    Oncol Rep. 2017 Aug 21. doi: 10.3892/or.2017.5911.
    PubMed     Text format     Abstract available


  29. LI Y, Zhou W, Tang K, Chen X, et al
    Silencing Aurora A leads to re-sensitization of breast cancer cells to Taxol through downregulation of SRC-mediated ERK and mTOR pathways.
    Oncol Rep. 2017 Aug 14. doi: 10.3892/or.2017.5908.
    PubMed     Text format     Abstract available


  30. LIU C, Liu Z, Li X, Tang X, et al
    MicroRNA-1297 contributes to tumor growth of human breast cancer by targeting PTEN/PI3K/AKT signaling.
    Oncol Rep. 2017 Aug 7. doi: 10.3892/or.2017.5884.
    PubMed     Text format     Abstract available


  31. ZHAO J, Zhi Z, Wang C, Xing H, et al
    Exogenous lipids promote the growth of breast cancer cells via CD36.
    Oncol Rep. 2017 Aug 1. doi: 10.3892/or.2017.5864.
    PubMed     Text format     Abstract available


    July 2017
  32. CHU S, Liu G, Xia P, Chen G, et al
    miR-93 and PTEN: Key regulators of doxorubicin-resistance and EMT in breast cancer.
    Oncol Rep. 2017 Jul 31. doi: 10.3892/or.2017.5859.
    PubMed     Text format     Abstract available


  33. YOU D, Jung SP, Jeong Y, Bae SY, et al
    Wild-type p53 controls the level of fibronectin expression in breast cancer cells.
    Oncol Rep. 2017 Jul 31. doi: 10.3892/or.2017.5860.
    PubMed     Text format     Abstract available


  34. FU X, Mao X, Wang Y, Ding X, et al
    Let-7c-5p inhibits cell proliferation and induces cell apoptosis by targeting ERCC6 in breast cancer.
    Oncol Rep. 2017 Jul 19. doi: 10.3892/or.2017.5839.
    PubMed     Text format     Abstract available


  35. MA SY, Park JH, Jung H, Ha SM, et al
    Snail maintains metastatic potential, cancer stem-like properties, and chemoresistance in mesenchymal mouse breast cancer TUBOP2J cells.
    Oncol Rep. 2017 Jul 18. doi: 10.3892/or.2017.5834.
    PubMed     Text format     Abstract available


  36. GUTIERREZ DIEZ PJ, Su Y, Russo J
    Immunocytochemical stem cell markers can predict clinical stage of breast cancer.
    Oncol Rep. 2017 Jul 14. doi: 10.3892/or.2017.5820.
    PubMed     Text format     Abstract available


  37. BARRON GA, Goua M, Wahle KWJ, Bermano G, et al
    Circulating levels of angiogenesis-related growth factors in breast cancer: A study to profile proteins responsible for tubule formation.
    Oncol Rep. 2017 Jul 11. doi: 10.3892/or.2017.5803.
    PubMed     Text format     Abstract available


  38. SHIBATA M, Kanda M, Tanaka H, Umeda S, et al
    Overexpression of Derlin 3 is associated with malignant phenotype of breast cancer cells.
    Oncol Rep. 2017 Jul 10. doi: 10.3892/or.2017.5800.
    PubMed     Text format     Abstract available


  39. YANG XL, Liu KY, Lin FJ, Shi HM, et al
    CCL28 promotes breast cancer growth and metastasis through MAPK-mediated cellular anti-apoptosis and pro-metastasis.
    Oncol Rep. 2017 Jul 7. doi: 10.3892/or.2017.5798.
    PubMed     Text format     Abstract available


  40. ZHONG J, Chen YJ, Chen L, Shen YY, et al
    PRMT2beta, a C-terminal splice variant of PRMT2, inhibits the growth of breast cancer cells.
    Oncol Rep. 2017 Jul 3. doi: 10.3892/or.2017.5786.
    PubMed     Text format     Abstract available


    June 2017
  41. SEO HS, Ku JM, Choi HS, Woo JK, et al
    Apigenin overcomes drug resistance by blocking the signal transducer and activator of transcription 3 signaling in breast cancer cells.
    Oncol Rep. 2017 Jun 26. doi: 10.3892/or.2017.5752.
    PubMed     Text format     Abstract available


  42. FENG YZ, Zhang QY, Fu MT, Zhang ZF, et al
    Low expression of PinX1 is associated with malignant behavior in basal-like breast cancer.
    Oncol Rep. 2017 Jun 2. doi: 10.3892/or.2017.5696.
    PubMed     Text format     Abstract available


    May 2017
  43. BHAT K, Sarkissyan M, Wu Y, Vadgama JV, et al
    GROalpha overexpression drives cell migration and invasion in triple negative breast cancer cells.
    Oncol Rep. 2017 May 24. doi: 10.3892/or.2017.5668.
    PubMed     Text format     Abstract available


  44. WANG Y, Peng Z, Meng R, Tao T, et al
    NHERF1 inhibits proliferation of triple-negative breast cancer cells by suppressing GPER signaling.
    Oncol Rep. 2017 May 18. doi: 10.3892/or.2017.5649.
    PubMed     Text format     Abstract available


  45. LI X, Chen W, Wang H, Wei Q, et al
    Amplification and the clinical significance of circulating cell-free DNA of PVT1 in breast cancer.
    Oncol Rep. 2017 May 18. doi: 10.3892/or.2017.5650.
    PubMed     Text format     Abstract available


  46. SHEN SQ, Huang LS, Xiao XL, Zhu XF, et al
    miR-204 regulates the biological behavior of breast cancer MCF-7 cells by directly targeting FOXA1.
    Oncol Rep. 2017 May 16. doi: 10.3892/or.2017.5644.
    PubMed     Text format     Abstract available


  47. SUN G, Yang L, Dong C, Ma B, et al
    PRKDC regulates chemosensitivity and is a potential prognostic and predictive marker of response to adjuvant chemotherapy in breast cancer patients.
    Oncol Rep. 2017 May 9. doi: 10.3892/or.2017.5634.
    PubMed     Text format     Abstract available


  48. CHEN Y, Luo D, Tian W, Li Z, et al
    Demethylation of miR-495 inhibits cell proliferation, migration and promotes apoptosis by targeting STAT-3 in breast cancer.
    Oncol Rep. 2017 May 3. doi: 10.3892/or.2017.5621.
    PubMed     Text format     Abstract available


  49. NANASHIMA N, Horie K, Yamada T, Shimizu T, et al
    Hair keratin KRT81 is expressed in normal and breast cancer cells and contributes to their invasiveness.
    Oncol Rep. 2017;37:2964-2970.
    PubMed     Text format     Abstract available


  50. HE J, Mai J, Li Y, Chen L, et al
    miR-597 inhibits breast cancer cell proliferation, migration and invasion through FOSL2.
    Oncol Rep. 2017;37:2672-2678.
    PubMed     Text format     Abstract available


  51. DIMAS-GONZALEZ J, Maldonado-Lagunas V, Diaz-Chavez J, Lopez-Arellano ME, et al
    Overexpression of p53 protein is a marker of poor prognosis in Mexican women with breast cancer.
    Oncol Rep. 2017;37:3026-3036.
    PubMed     Text format     Abstract available


  52. ANDERGASSEN U, Kolbl AC, Mumm JN, Mahner S, et al
    Triple-negative breast cancer: New therapeutic options via signalling transduction cascades.
    Oncol Rep. 2017;37:3055-3060.
    PubMed     Text format     Abstract available


    April 2017
  53. YEN MC, Kan JY, Hsieh CJ, Kuo PL, et al
    Association of long-chain acyl-coenzyme A synthetase 5 expression in human breast cancer by estrogen receptor status and its clinical significance.
    Oncol Rep. 2017 Apr 28. doi: 10.3892/or.2017.5610.
    PubMed     Text format     Abstract available


  54. ELMALLAH MIY, Micheau O, Eid MAG, Hebishy AMS, et al
    Marine actinomycete crude extracts with potent TRAIL-resistance overcoming activity against breast cancer cells.
    Oncol Rep. 2017 Apr 21. doi: 10.3892/or.2017.5595.
    PubMed     Text format     Abstract available


    March 2017
  55. THULASIRAMAN P, Garriga G, Danthuluri V, McAndrews DJ, et al
    Activation of the CRABPII/RAR pathway by curcumin induces retinoic acid mediated apoptosis in retinoic acid resistant breast cancer cells.
    Oncol Rep. 2017 Mar 8. doi: 10.3892/or.2017.5495.
    PubMed     Text format     Abstract available


  56. WOKOUN U, Hellriegel M, Emons G, Grundker C, et al
    Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors.
    Oncol Rep. 2017 Mar 6. doi: 10.3892/or.2017.5491.
    PubMed     Text format     Abstract available


  57. MEYNARD G, Mansi L, Lebahar P, Villanueva C, et al
    First description of a double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient: A case report.
    Oncol Rep. 2017;37:1573-1578.
    PubMed     Text format     Abstract available


  58. XU H, Qian M, Zhao B, Wu C, et al
    Inhibition of RAB1A suppresses epithelial-mesenchymal transition and proliferation of triple-negative breast cancer cells.
    Oncol Rep. 2017;37:1619-1626.
    PubMed     Text format     Abstract available


    February 2017
  59. GRIFFITH J, Andrade D, Mehta M, Berry W, et al
    Silencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy.
    Oncol Rep. 2017 Feb 28. doi: 10.3892/or.2017.5478.
    PubMed     Text format     Abstract available


  60. HUTH HW, Santos DM, Gravina HD, Resende JM, et al
    Upregulation of p38 pathway accelerates proliferation and migration of MDA-MB-231 breast cancer cells.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5452.
    PubMed     Text format     Abstract available


  61. LUO P, Lu G, Fan LL, Zhong X, et al
    Dysregulation of TMPRSS3 and TNFRSF11B correlates with tumorigenesis and poor prognosis in patients with breast cancer.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5449.
    PubMed     Text format     Abstract available


  62. ZHONG ZF, Tan W, Tian K, Yu H, et al
    Combined effects of furanodiene and doxorubicin on the migration and invasion of MDA-MB-231 breast cancer cells in vitro.
    Oncol Rep. 2017 Feb 10. doi: 10.3892/or.2017.5435.
    PubMed     Text format     Abstract available


  63. WU CW, Liu HC, Yu YL, Hung YT, et al
    Combined treatment with vitamin C and methotrexate inhibits triple-negative breast cancer cell growth by increasing H2O2 accumulation and activating caspase-3 and p38 pathways.
    Oncol Rep. 2017 Feb 10. doi: 10.3892/or.2017.5439.
    PubMed     Text format     Abstract available


  64. GIRGERT R, Emons G, Grundker C
    17beta-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib.
    Oncol Rep. 2017;37:1212-1218.
    PubMed     Text format     Abstract available


  65. HUANG Y, Jiang D, Sui M, Wang X, et al
    Fulvestrant reverses doxorubicin resistance in multidrug-resistant breast cell lines independent of estrogen receptor expression.
    Oncol Rep. 2017;37:705-712.
    PubMed     Text format     Abstract available


  66. LIN D, Kuang G, Wan J, Zhang X, et al
    Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of beta-catenin expression.
    Oncol Rep. 2017;37:895-902.
    PubMed     Text format     Abstract available


    January 2017
  67. CAI S, Sun PH, Resaul J, Shi L, et al
    Expression of phospholipase C isozymes in human breast cancer and their clinical significance.
    Oncol Rep. 2017 Jan 20. doi: 10.3892/or.2017.5394.
    PubMed     Text format     Abstract available


  68. WANG N, Wei L, Huang Y, Wu Y, et al
    miR520c blocks EMT progression of human breast cancer cells by repressing STAT3.
    Oncol Rep. 2017 Jan 19. doi: 10.3892/or.2017.5393.
    PubMed     Text format     Abstract available


  69. YANG Z, Liu Y, Shi C, Zhang Y, et al
    Suppression of PTEN/AKT signaling decreases the expression of TUBB3 and TOP2A with subsequent inhibition of cell growth and induction of apoptosis in human breast cancer MCF-7 cells via ATP and caspase-3 signaling pathways.
    Oncol Rep. 2017 Jan 9. doi: 10.3892/or.2017.5358.
    PubMed     Text format     Abstract available


  70. FU H, Fu L, Xie C, Zuo WS, et al
    miR-375 inhibits cancer stem cell phenotype and tamoxifen resistance by degrading HOXB3 in human ER-positive breast cancer.
    Oncol Rep. 2017 Jan 9. doi: 10.3892/or.2017.5360.
    PubMed     Text format     Abstract available


  71. CUI T, Zhang S, Sun H
    Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
    Oncol Rep. 2017 Jan 2. doi: 10.3892/or.2017.5345.
    PubMed     Text format     Abstract available


    December 2016
  72. WANG K, Sun X, Feng HL, Fei C, et al
    DNALK2 inhibits the proliferation and invasiveness of breast cancer MDA-MB-231 cells through the Smad-dependent pathway.
    Oncol Rep. 2016 Dec 30. doi: 10.3892/or.2016.5343.
    PubMed     Text format     Abstract available


  73. MENG C, Song L, Wang J, Li D, et al
    Propofol induces proliferation partially via downregulation of p53 protein and promotes migration via activation of the Nrf2 pathway in human breast cancer cell line MDA-MB-231.
    Oncol Rep. 2016 Dec 23. doi: 10.3892/or.2016.5332.
    PubMed     Text format     Abstract available


    November 2016
  74. LOU C, Zhu Z, Zhao Y, Zhu R, et al
    Arctigenin, a lignan from Arctium lappa L., inhibits metastasis of human breast cancer cells through the downregulation of MMP-2/-9 and heparanase in MDA-MB-231 cells.
    Oncol Rep. 2016 Nov 23. doi: 10.3892/or.2016.5269.
    PubMed     Text format     Abstract available


  75. LIU F, Zhang H, Song H
    Upregulation of MEK5 by Stat3 promotes breast cancer cell invasion and metastasis.
    Oncol Rep. 2016 Nov 18. doi: 10.3892/or.2016.5256.
    PubMed     Text format     Abstract available


  76. ZHOU T, Li Y, Yang L, Liu L, et al
    Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells.
    Oncol Rep. 2016 Nov 16. doi: 10.3892/or.2016.5251.
    PubMed     Text format     Abstract available


  77. XU X, Yan Q, Wang Y, Dong X, et al
    NTN4 is associated with breast cancer metastasis via regulation of EMT-related biomarkers.
    Oncol Rep. 2016 Nov 9. doi: 10.3892/or.2016.5239.
    PubMed     Text format     Abstract available


  78. JANG IS, Park JW, Jo EB, Cho CK, et al
    Growth inhibitory and apoptosis-inducing effects of allergen-free Rhus verniciflua Stokes extract on A549 human lung cancer cells.
    Oncol Rep. 2016;36:3037-3043.
    PubMed     Text format     Abstract available


  79. RATAJCZAK-WIELGOMAS K, Grzegrzolka J, Piotrowska A, Gomulkiewicz A, et al
    Periostin expression in cancer-associated fibroblasts of invasive ductal breast carcinoma.
    Oncol Rep. 2016;36:2745-2754.
    PubMed     Text format     Abstract available


  80. ARMANDO RG, Gomez DM, Gomez DE
    AZT exerts its antitumoral effect by telomeric and non-telomeric effects in a mammary adenocarcinoma model.
    Oncol Rep. 2016;36:2731-2736.
    PubMed     Text format     Abstract available


  81. IIZUKA A, Kondou R, Nonomura C, Ashizawa T, et al
    Unstable B7-H4 cell surface expression and T-cell redirection as a means of cancer therapy.
    Oncol Rep. 2016;36:2625-2632.
    PubMed     Text format     Abstract available


    October 2016
  82. LI M, Xiao D, Zhang J, Qu H, et al
    Expression of LPA2 is associated with poor prognosis in human breast cancer and regulates HIF-1alpha expression and breast cancer cell growth.
    Oncol Rep. 2016 Oct 26. doi: 10.3892/or.2016.5206.
    PubMed     Text format     Abstract available


  83. ZHAO W, Zhang X, Liu J, Sun B, et al
    miR-27a-mediated antiproliferative effects of metformin on the breast cancer cell line MCF-7.
    Oncol Rep. 2016 Oct 24. doi: 10.3892/or.2016.5199.
    PubMed     Text format     Abstract available


  84. ZHANG Z, Liu L, Liu C, Cao S, et al
    TIPE2 suppresses the tumorigenesis, growth and metastasis of breast cancer via inhibition of the AKT and p38 signaling pathways.
    Oncol Rep. 2016 Oct 21. doi: 10.3892/or.2016.5192.
    PubMed     Text format     Abstract available


  85. CHEN X, Li Q, Kan XX, Wang YJ, et al
    Extract of Caulis Spatholobi, a novel blocker targeting tumor cellinduced platelet aggregation, inhibits breast cancer metastasis.
    Oncol Rep. 2016 Oct 19. doi: 10.3892/or.2016.5184.
    PubMed     Text format     Abstract available


  86. CUI HX, Wang H, Wang Y, Song J, et al
    ST3Gal III modulates breast cancer cell adhesion and invasion by altering the expression of invasion-related molecules.
    Oncol Rep. 2016 Oct 18. doi: 10.3892/or.2016.5180.
    PubMed     Text format     Abstract available


  87. DU S, Li H, Sun X, Li D, et al
    MicroRNA-124 inhibits cell proliferation and migration by regulating SNAI2 in breast cancer.
    Oncol Rep. 2016 Oct 11. doi: 10.3892/or.2016.5163.
    PubMed     Text format     Abstract available


  88. BORDINHAO AL, Evangelista AF, Oliveira RJ, Macedo T, et al
    MicroRNA profiling in human breast cancer cell lines exposed to the anti-neoplastic drug cediranib.
    Oncol Rep. 2016 Oct 7. doi: 10.3892/or.2016.5153.
    PubMed     Text format     Abstract available


  89. ZHU C, Qi X, Zhou X, Nie X, et al
    Sulfatase 2 facilitates lymphangiogenesis in breast cancer by regulating VEGF-D.
    Oncol Rep. 2016 Oct 4. doi: 10.3892/or.2016.5143.
    PubMed     Text format     Abstract available


  90. MAO X, Qiao Z, Fan C, Guo A, et al
    Expression pattern and methylation of estrogen receptor alpha in breast intraductal proliferative lesions.
    Oncol Rep. 2016;36:1868-74.
    PubMed     Text format     Abstract available


    September 2016
  91. XUE D, Liang Y, Duan S, He J, et al
    Enhanced anti-tumor immunity against breast cancer induced by whole tumor cell vaccines genetically modified expressing alpha-Gal epitopes.
    Oncol Rep. 2016 Sep 23. doi: 10.3892/or.2016.5128.
    PubMed     Text format     Abstract available


  92. YAN F, Wang X, Zhu M, Hu X, et al
    RNAi-mediated downregulation of cyclin Y to attenuate human breast cancer cell growth.
    Oncol Rep. 2016 Sep 23. doi: 10.3892/or.2016.5126.
    PubMed     Text format     Abstract available


  93. YANG B, Zhao Y, Lou C, Zhao H, et al
    Eupalinolide O, a novel sesquiterpene lactone from Eupatorium lindleyanum DC., induces cell cycle arrest and apoptosis in human MDA-MB-468 breast cancer cells.
    Oncol Rep. 2016 Sep 21. doi: 10.3892/or.2016.5115.
    PubMed     Text format     Abstract available


  94. ZHANG L, Chen Z, Xue D, Zhang Q, et al
    Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker.
    Oncol Rep. 2016 Sep 20. doi: 10.3892/or.2016.5112.
    PubMed     Text format     Abstract available


  95. WEI YC, Zhang B, Li X, Liu XM, et al
    Upregulation and activation of deltaopioid receptors promotes the progression of human breast cancer.
    Oncol Rep. 2016 Sep 19. doi: 10.3892/or.2016.5109.
    PubMed     Text format     Abstract available


  96. OSANAI M, Lee GH
    CYP24A1-induced vitamin D insufficiency promotes breast cancer growth.
    Oncol Rep. 2016 Sep 5. doi: 10.3892/or.2016.5072.
    PubMed     Text format     Abstract available


  97. MA T, Yang L, Zhang J
    GPRC5A exerts its tumor-suppressive effects in breast cancer cells by inhibiting EGFR and its downstream pathway.
    Oncol Rep. 2016 Sep 2. doi: 10.3892/or.2016.5062.
    PubMed     Text format     Abstract available


    August 2016
  98. XU L, Peng S, Huang Q, Liu Y, et al
    Expression status of cyclaseassociated protein 2 as a prognostic marker for human breast cancer.
    Oncol Rep. 2016 Aug 25. doi: 10.3892/or.2016.5051.
    PubMed     Text format     Abstract available


  99. WANG Z, Jin J, Zhang J, Wang L, et al
    Depletion of SENP1 suppresses the proliferation and invasion of triple-negative breast cancer cells.
    Oncol Rep. 2016 Aug 24. doi: 10.3892/or.2016.5036.
    PubMed     Text format     Abstract available


  100. JI Y, Han Z, Shao L, Zhao Y, et al
    Ultrasound-targeted microbubble destruction of calcium channel subunit alpha 1D siRNA inhibits breast cancer via G protein-coupled receptor 30.
    Oncol Rep. 2016 Aug 23. doi: 10.3892/or.2016.5031.
    PubMed     Text format     Abstract available


  101. MATSUI S, Kagara N, Mishima C, Naoi Y, et al
    Methylation of the SEPT9_v2 promoter as a novel marker for the detection of circulating tumor DNA in breast cancer patients.
    Oncol Rep. 2016 Aug 4. doi: 10.3892/or.2016.5004.
    PubMed     Text format     Abstract available


    July 2016
  102. HAN J, Jeon M, Shin I, Kim S, et al
    Elevated STC1 augments the invasiveness of triplenegative breast cancer cells through activation of the JNK/cJun signaling pathway.
    Oncol Rep. 2016 Jul 26. doi: 10.3892/or.2016.4977.
    PubMed     Text format     Abstract available


  103. JEON M, Han J, Nam SJ, Lee JE, et al
    STC-1 expression is upregulated through an Akt/NF-kappaB-dependent pathway in triple-negative breast cancer cells.
    Oncol Rep. 2016 Jul 25. doi: 10.3892/or.2016.4972.
    PubMed     Text format     Abstract available


  104. SUN J, Zhang X, Han Y, Zhen J, et al
    Overexpression of seven in absentia homolog 2 protein in human breast cancer tissues is associated with the promotion of tumor cell malignant behavior in in vitro.
    Oncol Rep. 2016 Jul 25. doi: 10.3892/or.2016.4976.
    PubMed     Text format     Abstract available


  105. FU OY, Chang HW, Lin YD, Chuang LY, et al
    Breast cancer-associated high-order SNP-SNP interaction of CXCL12/CXCR4-related genes by an improved multifactor dimensionality reduction (MDR-ER).
    Oncol Rep. 2016 Jul 21. doi: 10.3892/or.2016.4956.
    PubMed     Text format     Abstract available


  106. WANG J, Cui L, Feng L, Zhang Z, et al
    Isoalantolactone inhibits the migration and invasion of human breast cancer MDA-MB-231 cells via suppression of the p38 MAPK/NF-kappaB signaling pathway.
    Oncol Rep. 2016 Jul 20. doi: 10.3892/or.2016.4954.
    PubMed     Text format     Abstract available


  107. CHEN J, Wang F, Xu J, He Z, et al
    The role of PAQR3 gene promoter hypermethylation in breast cancer and prognosis.
    Oncol Rep. 2016 Jul 19. doi: 10.3892/or.2016.4951.
    PubMed     Text format     Abstract available


  108. KONG Y, Lu ZL, Wang JJ, Zhou R, et al
    Platycodin D, a metabolite of Platycodin grandiflorum, inhibits highly metastatic MDA-MB-231 breast cancer growth in vitro and in vivo by targeting the MDM2 oncogene.
    Oncol Rep. 2016 Jul 13. doi: 10.3892/or.2016.4935.
    PubMed     Text format     Abstract available


  109. GOMES BC, Martins M, Lopes P, Morujao I, et al
    Prognostic value of microRNA-203a expression in breast cancer.
    Oncol Rep. 2016 Jul 5. doi: 10.3892/or.2016.4913.
    PubMed     Text format     Abstract available


    June 2016
  110. PISTELLI M, Ballatore Z, Santinelli A, Biscotti T, et al
    Phosphorylated mTOR is associated to androgen receptor expression in early triple-negative breast cancer.
    Oncol Rep. 2016 Jun 22. doi: 10.3892/or.2016.4903.
    PubMed     Text format     Abstract available


  111. XIE YG, Yu Y, Hou LK, Wang X, et al
    FYN promotes breast cancer progression through epithelial-mesenchymal transition.
    Oncol Rep. 2016 Jun 22. doi: 10.3892/or.2016.4894.
    PubMed     Text format     Abstract available


  112. ZHAO L, Feng X, Song X, Zhou H, et al
    miR-493-5p attenuates the invasiveness and tumorigenicity in human breast cancer by targeting FUT4.
    Oncol Rep. 2016 Jun 16. doi: 10.3892/or.2016.4882.
    PubMed     Text format     Abstract available


  113. GUO L, Zheng J, Zhang J, Wang H, et al
    Knockdown of TAZ modifies triple-negative breast cancer cell sensitivity to EGFR inhibitors by regulating YAP expression.
    Oncol Rep. 2016 Jun 15. doi: 10.3892/or.2016.4875.
    PubMed     Text format     Abstract available


  114. MAYNADIER M, Basile I, Gallud A, Gary-Bobo M, et al
    Combination treatment with proteasome inhibitors and antiestrogens has a synergistic effect mediated by p21WAF1 in estrogen receptor-positive breast cancer.
    Oncol Rep. 2016 Jun 14. doi: 10.3892/or.2016.4873.
    PubMed     Text format     Abstract available


  115. LI M, Cai H, Yang Y, Zhang J, et al
    Perichondrium mesenchymal stem cells inhibit the growth of breast cancer cells via the DKK-1/Wnt/beta-catenin signaling pathway.
    Oncol Rep. 2016 Jun 3. doi: 10.3892/or.2016.4853.
    PubMed     Text format     Abstract available


    May 2016
  116. ZHANG YF, Yu Y, Song WZ, Zhang RM, et al
    miR-410-3p suppresses breast cancer progression by targeting Snail.
    Oncol Rep. 2016 May 23. doi: 10.3892/or.2016.4828.
    PubMed     Text format     Abstract available


  117. KARIM S, Merdad A, Schulten HJ, Jayapal M, et al
    Low expression of leptin and its association with breast cancer: A transcriptomic study.
    Oncol Rep. 2016 May 13. doi: 10.3892/or.2016.4806.
    PubMed     Text format     Abstract available


  118. ZHANG X, Lin D, Jiang R, Li H, et al
    Ferulic acid exerts antitumor activity and inhibits metastasis in breast cancer cells by regulating epithelial to mesenchymal transition.
    Oncol Rep. 2016 May 12. doi: 10.3892/or.2016.4804.
    PubMed     Text format     Abstract available


  119. YU F, Zhao J, Hu Y, Zhou Y, et al
    The combination of NVP-BKM120 with trastuzumab or RAD001 synergistically inhibits the growth of breast cancer stem cells in vivo.
    Oncol Rep. 2016 May 10. doi: 10.3892/or.2016.4799.
    PubMed     Text format     Abstract available


  120. JIANG Q, Pan Y, Cheng Y, Li H, et al
    Lunasin suppresses the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2/-9 via the FAK/Akt/ERK and NF-kappaB signaling pathways.
    Oncol Rep. 2016 May 9. doi: 10.3892/or.2016.4798.
    PubMed     Text format     Abstract available


  121. LIU Q, Wang W, Yang X, Zhao D, et al
    MicroRNA-146a inhibits cell migration and invasion by targeting RhoA in breast cancer.
    Oncol Rep. 2016 May 6. doi: 10.3892/or.2016.4788.
    PubMed     Text format     Abstract available


  122. ZHAO Y, Jing Z, Li Y, Mao W, et al
    Berberine in combination with cisplatin suppresses breast cancer cell growth through induction of DNA breaks and caspase-3-dependent apoptosis.
    Oncol Rep. 2016 May 5. doi: 10.3892/or.2016.4785.
    PubMed     Text format     Abstract available


  123. SEO HS, Ku JM, Choi HS, Choi YK, et al
    Quercetin induces caspase-dependent extrinsic apoptosis through inhibition of signal transducer and activator of transcription 3 signaling in HER2-overexpressing BT-474 breast cancer cells.
    Oncol Rep. 2016 May 5. doi: 10.3892/or.2016.4786.
    PubMed     Text format     Abstract available


  124. INNAJAK S, Mahabusrakum W, Watanapokasin R
    Goniothalamin induces apoptosis associated with autophagy activation through MAPK signaling in SK-BR-3 cells.
    Oncol Rep. 2016;35:2851-8.
    PubMed     Text format     Abstract available


  125. IZDEBSKA M, Grzanka D, Gagat M, Halas-Wisniewska M, et al
    Downregulation of importin-9 protects MCF-7 cells against apoptosis induced by the combination of garlic-derived alliin and paclitaxel.
    Oncol Rep. 2016;35:3084-93.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: